NDAINTRAVENOUSSOLUTION
Approved
Mar 2017
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
4/8 — Partial
EPHEDRINE SULFATE (ephedrine sulfate) by Dr. Reddy's Laboratories is α- and ß adrenergic receptors and indirectly causes the release of norepinephrine from sympathetic neurons. Approved for clinically important hypotension occurring in the setting of anesthesia. First approved in 2017.
Drug data last refreshed 10h ago · AI intelligence enriched 4w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Ephedrine sulfate is a small-molecule sympathomimetic amine that activates α- and β-adrenergic receptors both directly and indirectly via norepinephrine release from sympathetic neurons. It is indicated for clinically important hypotension occurring during anesthesia, working to restore arterial pressure, cardiac output, and peripheral resistance. The IV solution formulation allows rapid hemodynamic stabilization in perioperative settings.
Peak
Product is in peak commercial lifecycle with established market presence; team size and growth dependent on anesthesia/acute care market dynamics and competitive positioning.
Mechanism of Action
α- and ß adrenergic receptors and indirectly causes the release of norepinephrine from sympathetic neurons. Pressor effects by direct alpha- and beta-adrenergic receptor activation are mediated by increases in arterial pressures, cardiac output, and peripheral resistance. Indirect adrenergic…
Clinical Trials (1)
Bioequivalence Study of Desloratadine and Pseudoephedrine Sulfate Extended-release Tablets Under Fasting Conditions
Started Apr 2006
34 enrolled
Healthy
Worked on EPHEDRINE SULFATE at Dr. Reddy's Laboratories? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.